Allied Market Research
Loading...
0
2021
Contraceptive Drugs Market

Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15–24 Years, 25–34 Years, 35–44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020–2027

A09485
Pages: 168
Jan 2021 | 1998 Views
   
Author(s) : Trupti Wadekar, Snehal Manjrekar , Onkar Sumant
Tables: 98
Charts: 45
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Contraceptive Drugs Market

Request Now !

Contraceptive Drugs Market Overview:

The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during the forecast period. Contraception is a method to prevent unwanted pregnancy, control birth rate, and reduce the risk of sexually transmitted diseases (STDs). Contraception involves the use of drugs in the form of oral pills, injectable contraceptives, and topical contraceptives. These drugs are used among women of childbearing age after puberty and before menopause, that is, between 15 and 44 years of age.  Contraceptive drugs are used by a set of end users to prevent pregnancy & STIs and for birth control & family planning. Increase in concerns about family planning and necessity to prevent unintended pregnancy are some of the major factors driving the growth of the global contraceptive drugs market. Furthermore, upsurge in the use of contraception among young women and increase in higher educational attainment promote the market growth. Furthermore, health problems allied with teenage pregnancies, surge in awareness regarding modern contraception methods, and increase in the usage of oral pills as a crucial technique to avert unplanned pregnancy are expected to propel the growth of the market in the years to come. However, health risks associated with the use of contraceptives, accessibility of alternate contraceptive methods, and less social acceptance negatively impact the contraceptive drugs market growth.

COVID-19 impact

Nationwide lockdown imposed across the globe in an effort to combat COVID-19 pandemic has adversely affected the contraceptive market. Most of the women are unable to access and purchase pills or visit a healthcare center for receiving an injectable. Moreover, contraceptive drug manufacturers were facing newer challenges with inconsistent and interrupted supply chain activities and availability of human resources. However, as the restrictions are easing globally, the market is expected to gain traction in coming years, owing to increase in online availability of contraceptive drugs as well as pharmacies. Manufacturers are likely to face challenges in coping up with demand and supply side. 

contraceptive-drugs-Market-2020-2027

Get more information on this report : Request Sample Pages

Product segment review

Depending on product, the contraceptive drugs are categorized into oral (pills), injectable, and topical contraceptives. Oral contraceptive drugs or oral contraceptive pills segment accounted for over 85.36% share in the global contraceptive drugs market in 2019. Oral pills are the most common type of reversible contraception used worldwide. Higher effectiveness and better convenience have made them a preferred form of contraception over the past few years. In addition, large consumer base and proactive government initiatives to cater the unmet needs of contraception have boosted the market growth. However, the injectable contraceptives segment is estimated to register a CAGR of 8.0% during the forecast period, due to rise in awareness of injectables available in the market and growth in population.

Contraceptive Drugs Market
By Product

Your browser does not support the canvas element.

Oral Contraceptive Drugs segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Age group segment review

On the basis of age group, women in the age group of 15–24 years dominated the global contraceptive drugs market in 2019. This is attributed to the augmented use of contraceptives among teenagers, early maturity among teenage girls, and increase in demand for contraceptives. Conversely, women aged above 44 years are the least contributors to the contraceptive drugs market growth, owing to the menopause in women at the age 44 years and above.

Contraceptive Drugs Market
By Age Group

Your browser does not support the canvas element.

15-24 years segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

End-user segment review

By end user, the market is classified into homecare, hospitals, and clinics. The homecare segment accounted for the largest share in the global contraceptive market, owing to the wide consumption of oral pills to prevent unplanned pregnancy and STIs. Contraceptives that are preferred in home settings comprise oral pills, topical contraceptives, and contraceptive patches. These contraceptives help to reduce the risk of pregnancy and chance of getting STIs. Increase in use of contraceptive drugs at home has improved health-related outcomes such as maternal & infant mortality; reduced the risk of STI such as HIV, hepatitis B, syphilis, and gonorrhea; and improved economic outcomes of a family.

Contraceptive Drugs Market
By End User

Your browser does not support the canvas element.

Household segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region segment review

North America accounted for majority of the share in the global contraceptive drugs market in 2019. This region is projected to uphold its lead throughout the analysis period, owing to rise in awareness regarding contraceptive pills, surge in adoption of modern contraceptive drugs, and alarming rise in prevalence of sexually transmitted diseases such as HIV/AIDS. U.S. accounts for the significant share in the overall North American contraceptive drugs market. Asia-Pacific is anticipated to grow at the fastest pace during the forecast period, due to presence of large population base and proactive initiatives of governmental organizations for birth control and awareness within the developing countries. In addition, availability of cost-effective contraceptive drugs in this region proposes profitable opportunities to contraceptive drug manufacturers. Launch of awareness programs by government agencies and other regulatory bodies to increase the homecare usage of contraceptive drugs drives the market growth in the Asia-Pacific and LAMEA.

Contraceptive Drugs Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2019 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

The key players profiled in this report include Agile Therapeutics, Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Piramal Healthcare, Mylan N.V., Pfizer Inc., Novartis AG and Teva Pharmaceutical Industries Ltd. Other players operating in the market are HLL Lifecare ltd,  and Sanofi.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current contraceptive drugs market trends and forecast estimations from 2019 to 2027, which assists to identify the prevailing contraceptive drugs market opportunities. 
  • An in-depth contraceptive drugs market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future contraceptive drugs market potential from 2020 to 2027, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the contraceptive drugs market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of global contraceptive drugs market.

Key Market Segments

  • By Age Group
    • 15–24 years
    • 25–34 years
    • 35–44 years
    • Above 44 years
  • By Product
    • Oral Contraceptive Pills
    • Injectable Contraceptives
    • Topical Contraceptives
  • By End User
    • Homecare
    • Hospitals
    • Clinics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Agile Therapeutics
  • Allergan Plc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Piramal Healthcare
  • Mylan N.V.
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key Findings of the Study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in need for preventing unwanted pregnancy
3.3.1.2.Increasing awareness for contraceptives worldwide
3.3.1.3.Rising usage of oral contraceptives as a preferred method to avoid unplanned pregnancy
3.3.1.4.Upsurge in government and NGO initiatives promoting contraceptives
3.3.1.5.Increasing awareness about STDs

3.3.2.Restraints

3.3.2.1.Health risks associated with the use of contraceptive methods
3.3.2.2.Lack of social acceptance

3.3.3.Opportunity

3.3.3.1.Rise in disposable income and demand for healthy life in emerging economies
3.3.3.2.Presence of large unmet contraceptive needs in emerging asian and african economies

3.4.COVID Impact on the market

CHAPTER 4:CONTRACEPTIVE DRUGS MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Oral contraceptive pills

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Injectable contraceptives

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Topical contraceptives

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.15–24 years

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.25–34 years

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.35–44 years

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Above 44 years

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:CONTRACEPTIVE DRUGS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Homecare

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Hospitals

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Clinics

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:CONTRACEPTIVE DRUGS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.North America contraceptive drugs market by product
7.2.4.North America contraceptive drugs market by age group
7.2.5.North America contraceptive drugs market by end user
7.2.6.U.S.

7.2.6.1.U.S. contraceptive drugs market by product
7.2.6.2.U.S. contraceptive drugs market by age group
7.2.6.3.U.S. contraceptive drugs market by end user

7.2.7.Canada

7.2.7.1.Canada contraceptive drugs market by product
7.2.7.2.Canada contraceptive drugs market by age group
7.2.7.3.Canada contraceptive drugs market by end user

7.2.8.Mexico

7.2.8.1.Mexico contraceptive drugs market by product
7.2.8.2.Mexico contraceptive drugs market by age group
7.2.8.3.Mexico contraceptive drugs market by end user

7.3.Europe

7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Europe contraceptive drugs market by product
7.3.4.Europe contraceptive drugs market by age group
7.3.5.Europe contraceptive drugs market by end user
7.3.6.Germany

7.3.6.1.Germany contraceptive drugs market by product
7.3.6.2.Germany contraceptive drugs market by age group
7.3.6.3.Germany contraceptive drugs market by end user

7.3.7.France

7.3.7.1.France contraceptive drugs market by product
7.3.7.2.France contraceptive drugs market by age group
7.3.7.3.France contraceptive drugs market by end user

7.3.8.UK

7.3.8.1.UK contraceptive drugs market by product
7.3.8.2.UK contraceptive drugs market by age group
7.3.8.3.UK contraceptive drugs market by end user

7.3.9.Rest of Europe

7.3.9.1.Rest of Europe contraceptive drugs market by product
7.3.9.2.Rest of Europe contraceptive drugs market by age group
7.3.9.3.Rest of Europe contraceptive drugs market by end user

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific contraceptive drugs market by product
7.4.4.Asia-Pacific contraceptive drugs market by age group
7.4.5.Asia-Pacific contraceptive drugs market by end user
7.4.6.Japan

7.4.6.1.Japan contraceptive drugs market by product
7.4.6.2.Japan contraceptive drugs market by age group
7.4.6.3.Japan contraceptive drugs market by end user

7.4.7.China

7.4.7.1.China contraceptive drugs market by product
7.4.7.2.China contraceptive drugs market by age group
7.4.7.3.China contraceptive drugs market by end user

7.4.8.Australia

7.4.8.1.Australia contraceptive drugs market by product
7.4.8.2.Australia contraceptive drugs market by age group
7.4.8.3.Australia contraceptive drugs market by end user

7.4.9.India

7.4.9.1.India contraceptive drugs market by product
7.4.9.2.India contraceptive drugs market by age group
7.4.9.3.India contraceptive drugs market by end user

7.4.10.Rest of Asia-Pacific

7.4.10.1.Rest of Asia-Pacific contraceptive drugs market by product
7.4.10.2.Rest of Asia-Pacific contraceptive drugs market by age group
7.4.10.3.Rest of Asia-Pacific contraceptive drugs market by end user

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA contraceptive drugs market by product
7.5.4.LAMEA contraceptive drugs market by age group
7.5.5.LAMEA contraceptive drugs market by end user
7.5.6.Brazil

7.5.6.1.Brazil contraceptive drugs market by product
7.5.6.2.Brazil contraceptive drugs market by age group
7.5.6.3.Brazil contraceptive drugs market by end user

7.5.7.Saudi Arabia

7.5.7.1.Saudi Arabia contraceptive drugs market by product
7.5.7.2.Saudi Arabia contraceptive drugs market by age group
7.5.7.3.Saudi Arabia contraceptive drugs market by end user

7.5.8.South Africa

7.5.8.1.South Africa contraceptive drugs market by product
7.5.8.2.South Africa contraceptive drugs market by age group
7.5.8.3.South Africa contraceptive drugs market by end user

7.5.9.Rest of LAMEA

7.5.9.1.Rest of LAMEA contraceptive drugs market by product
7.5.9.2.Rest of LAMEA contraceptive drugs market by age group
7.5.9.3.Rest of LAMEA contraceptive drugs market by end user

CHAPTER 8:COMPANY PROFILES

8.1.Agile Therapeutics

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Business performance

8.2.Allergan Plc.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Business performance

8.3.Bayer AG

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Business performance

8.4.GlaxoSmithKline Plc

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Business performance
8.4.5.Key strategic moves and developments

8.5.Johnson & Johnson

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Business performance
8.5.5.Key strategic moves and developments

8.6.Piramal Healthcare

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Business performance

8.7.Mylan N.V.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Business performance

8.8.Pfizer Inc.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Business performance
8.8.5.Key strategic moves and developments

8.9.Novartis AG

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Business performance
8.9.5.Key strategic moves and developments

8.10.Teva Pharmaceutical Industries Ltd.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Business performance
8.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.CONTRACEPTIVE DRUGS MARKET FOR ORAL CONTRACEPTIVES, BY REGION, 2019–2027 ($MILLION)
TABLE 03.CONTRACEPTIVE DRUGS MARKET FOR INJECTABLE CONTRACEPTIVES, BY REGION, 2019–2027 ($MILLION)
TABLE 04.CONTRACEPTIVE DRUGS MARKET FOR TOPICAL CONTRACEPTIVES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019–2027 ($MILLION)
TABLE 06.CONTRACEPTIVE DRUGS MARKET FOR 15–24 YEARS, BY REGION, 2019–2027 ($MILLION)
TABLE 07.CONTRACEPTIVE DRUGS MARKET FOR 25–34 YEARS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.CONTRACEPTIVE DRUGS MARKET FOR 35–44 YEARS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.CONTRACEPTIVE DRUGS MARKET FOR ABOVE 44 YEARS, BY REGION, 2019–2027 ($MILLION)
TABLE 10.CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 11.CONTRACEPTIVE DRUGS MARKET FOR HOMECARE, BY REGION, 2019–2027 ($MILLION)
TABLE 12.CONTRACEPTIVE DRUGS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CONTRACEPTIVE DRUGS MARKET FOR CLINICS, BY REGION, 2019–2027 ($MILLION)
TABLE 14.CONTRACEPTIVE DRUGS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NORTH AMERICA CONTRACEPTIVE DRUGS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 16.NORTH AMERICA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 17.NORTH AMERICA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 18.NORTH AMERICA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 19.U.S. CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 20.U.S. CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 21.U.S. CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 22.CANADA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 23.CANADA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 24.CANADA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 25.MEXICO CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 26.MEXICO CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 27.MEXICO CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 28.EUROPE CONTRACEPTIVE DRUGS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 29.EUROPE CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 30.EUROPE CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 31.EUROPE CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 32.GERMANY CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 33.GERMANY CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 34.GERMANY CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 35.FRANCE CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 36.FRANCE CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 37.FRANCE CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 38.UK CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 39.UK CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 40.UK CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 41.REST OF EUROPE CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 42.REST OF EUROPE CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 43.REST OF EUROPE CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 44.ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 45.ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 46.ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 47.ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 48.JAPAN CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 49.JAPAN CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 50.JAPAN CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 51.CHINA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 52.CHINA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 53.CHINA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 54.AUSTRALIA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 55.AUSTRALIA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 56.AUSTRALIA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 57.INDIA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 58.INDIA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 59.INDIA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 61.REST OF ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 62.REST OF ASIA-PACIFIC CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 63.LAMEA CONTRACEPTIVE DRUGS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 64.LAMEA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 65.LAMEA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 66.LAMEA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 67.BRAZIL CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 68.BRAZIL CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 69.BRAZIL CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 70.SAUDI ARABIA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 71.SAUDI ARABIA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 72.SAUDI ARABIA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 73.SOUTH AFRICA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 74.SOUTH AFRICA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 75.SOUTH AFRICA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 76.REST OF LAMEA CONTRACEPTIVE DRUGS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 77.REST OF LAMEA CONTRACEPTIVE DRUGS MARKET, BY AGE GROUP, 2019-2027 ($MILLION)
TABLE 78.REST OF LAMEA CONTRACEPTIVE DRUGS MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 79.AGILE THERAPEUTICS: COMPANY SNAPSHOT
TABLE 80.AGILE THERAPEUTICS: OPERATING SEGMENTS
TABLE 81.ALLERGAN: COMPANY SNAPSHOT
TABLE 82.ALLERGAN: OPERATING SEGMENTS
TABLE 83.BAYER: COMPANY SNAPSHOT
TABLE 84.BAYER: OPERATING SEGMENTS
TABLE 85.GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 86.GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 87.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 88.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 89.PIRAMAL HEALTHCARE: COMPANY SNAPSHOT
TABLE 90.PIRAMAL HEALTHCARE: OPERATING SEGMENTS
TABLE 91.MYLAN: COMPANY SNAPSHOT
TABLE 92.MYLAN: OPERATING SEGMENTS
TABLE 93.PFIZER: COMPANY SNAPSHOT
TABLE 94.PFIZER: OPERATING SEGMENTS
TABLE 95.NOVARTIS: COMPANY SNAPSHOT
TABLE 96.NOVARTIS: OPERATING SEGMENTS
TABLE 97.TEVA: COMPANY SNAPSHOT
TABLE 98.TEVA: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01.CONTRACEPTIVE DRUGS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MARKET DYNAMICS: CONTRCEPTIVE DRUGS MARKET
FIGURE 04.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR ORAL CONTRACEPTIVES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 05.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR INJECTABLE CONTRACEPTIVES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 06.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR TOPICAL CONTRACEPTIVES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 07.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR 15–24 YEARS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 08.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR 25–34 YEARS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 09.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR 35–44 YEARS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 10.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR ABOVE 44 YEARS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 11.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR HOMECARE, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF CONTRACEPTIVE DRUGS MARKET FOR CLINICS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 14.CANCER SURVIVOR PREDICTIONS IN U.S.
FIGURE 15.CANCER INCIDENCES IN GERMANY (2007 & 2050)
FIGURE 16.AGILE THERAPEUTICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 17.AGILE THERAPEUTICS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 18.AGILE THERAPEUTICS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 19.ALLERGAN: NET SALES, 2017–2019 ($MILLION)
FIGURE 20.ALLERGAN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 21.ALLERGAN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 22.BAYER: NET SALES, 2017–2019 ($MILLION)
FIGURE 23.BAYER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 24.BAYER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 25.GLAXOSMITHKLINE PLC: NET SALES, 2017–2019 ($MILLION)
FIGURE 26.GLAXOSMITHKLINE PLC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 27.GLAXOSMITHKLINE PLC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 28.JOHNSON & JOHNSON: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.PIRAMAL HEALTHCARE: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.PIRAMAL HEALTHCARE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.PIRAMAL HEALTHCARE: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.MYLAN: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.MYLAN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.MYLAN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.PFIZER: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.PFIZER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 39.PFIZER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 40.NOVARTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.NOVARTIS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 42.NOVARTIS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 43.TEVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.TEVA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 45.TEVA: REVENUE SHARE BY REGION, 2019 (%)

 
 

The utilization rate of contraceptive drugs is expected to increase due to alarming rise in incidence of sexually transmitted diseases (STDs) and need for birth control. The contraceptive drugs market has piqued the interest of healthcare providers, due to the benefits offered by these drugs to prevent unwanted pregnancy.

Homecare users reported for a substantial share in the contraceptive drugs market, due to the use of user-friendly contraceptive methods such as pills and topical contraceptives. Contraceptive drug manufacturers have focused on marketing novel contraceptives for homecare users through various media such as television and internet. 

Research and development on contraceptive drugs have led to the introduction of advanced contraceptive options for population control, transmission of STDs, and prevention of unwanted pregnancy. Rise in incidence of STDs, increase in number of unwanted pregnancies, and emphasis on the prevention of immature pregnancy & abortions are some of the driving factors of the market. However, social, ethical, and religious barriers and beliefs hamper the market growth. Currently, the oral contraceptive or pill segment has the largest revenue share in the contraceptive drugs market, followed by injectable contraceptives. 

Asia-Pacific is expected to be the most promising regional market for contraceptive drugs. Government organizations and NGOs have taken initiatives toward population control, prevention of unintentional pregnancies, and transmission of STDs among low-income groups. In addition, emerging markets have been gaining importance due the growing population in this region. Rapid growth in shipments of these drugs was observed to provide improved healthcare services in the emerging nations, especially Japan. This is expected to offset the challenging conditions in the mature markets such as North America and Europe. North America is expected to dominate the global contraceptive drugs market during the forecast period, followed by Europe.
 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The key trends in the contraceptive drugs Market are increase in awareness regarding STDs among population and avoid unwanted pregnancy among women

A. No, there is no value chain analysis provided in the contraceptive drugs Market report

A. The top companies that hold the market share in contraceptive drugs Market are Agile Therapeutics, Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Merck & Co., Inc., Mylan N.V., Pfizer Inc.

A. The total market value of contraceptive drugs Market is $14,324.12 million in 2019

A. The forecast period in the report is from 2020 to 2027

A. The market value of contraceptive drugs Market in 2020 was $15,255.18 Million

A. The base year for the report is 2019

A. Yes, contraceptive drugs companies are profiled in the report

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Contraceptive Drugs Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers